vs
Side-by-side financial comparison of APPFOLIO INC (APPF) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
APPFOLIO INC is the larger business by last-quarter revenue ($262.2M vs $205.4M, roughly 1.3× COLLEGIUM PHARMACEUTICAL, INC). APPFOLIO INC runs the higher net margin — 16.2% vs 8.3%, a 7.9% gap on every dollar of revenue. On growth, APPFOLIO INC posted the faster year-over-year revenue change (20.4% vs 12.9%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 15.3%).
AppFolio, Inc. is an American company founded in 2006 that offers software-as-a-service (SaaS) applications and services to the real estate industry.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
APPF vs COLL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $262.2M | $205.4M |
| Net Profit | $42.4M | $17.0M |
| Gross Margin | — | 62.5% |
| Operating Margin | 19.4% | 29.6% |
| Net Margin | 16.2% | 8.3% |
| Revenue YoY | 20.4% | 12.9% |
| Net Profit YoY | 35.2% | 35.3% |
| EPS (diluted) | $1.18 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $262.2M | — | ||
| Q4 25 | $248.2M | $205.4M | ||
| Q3 25 | $249.4M | $209.4M | ||
| Q2 25 | $235.6M | $188.0M | ||
| Q1 25 | $217.7M | $177.8M | ||
| Q4 24 | $203.7M | $181.9M | ||
| Q3 24 | $205.7M | $159.3M | ||
| Q2 24 | $197.4M | $145.3M |
| Q1 26 | $42.4M | — | ||
| Q4 25 | $39.9M | $17.0M | ||
| Q3 25 | $33.6M | $31.5M | ||
| Q2 25 | $36.0M | $12.0M | ||
| Q1 25 | $31.4M | $2.4M | ||
| Q4 24 | $102.7M | $12.5M | ||
| Q3 24 | $33.0M | $9.3M | ||
| Q2 24 | $29.7M | $19.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 62.5% | ||
| Q3 25 | — | 61.7% | ||
| Q2 25 | — | 57.7% | ||
| Q1 25 | — | 54.8% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 60.8% | ||
| Q2 24 | — | 62.5% |
| Q1 26 | 19.4% | — | ||
| Q4 25 | 17.6% | 29.6% | ||
| Q3 25 | 14.1% | 29.7% | ||
| Q2 25 | 17.2% | 18.7% | ||
| Q1 25 | 15.5% | 12.2% | ||
| Q4 24 | 11.3% | 20.9% | ||
| Q3 24 | 20.7% | 21.9% | ||
| Q2 24 | 18.3% | 32.7% |
| Q1 26 | 16.2% | — | ||
| Q4 25 | 16.1% | 8.3% | ||
| Q3 25 | 13.5% | 15.0% | ||
| Q2 25 | 15.3% | 6.4% | ||
| Q1 25 | 14.4% | 1.4% | ||
| Q4 24 | 50.4% | 6.9% | ||
| Q3 24 | 16.0% | 5.9% | ||
| Q2 24 | 15.0% | 13.5% |
| Q1 26 | $1.18 | — | ||
| Q4 25 | $1.10 | $0.48 | ||
| Q3 25 | $0.93 | $0.84 | ||
| Q2 25 | $0.99 | $0.34 | ||
| Q1 25 | $0.86 | $0.07 | ||
| Q4 24 | $2.79 | $0.36 | ||
| Q3 24 | $0.90 | $0.27 | ||
| Q2 24 | $0.81 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.4M | $386.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $470.2M | $301.7M |
| Total Assets | $580.6M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $147.4M | — | ||
| Q4 25 | $107.0M | $386.7M | ||
| Q3 25 | $76.1M | $285.9M | ||
| Q2 25 | $73.5M | $222.2M | ||
| Q1 25 | $56.9M | $197.8M | ||
| Q4 24 | $42.5M | $162.8M | ||
| Q3 24 | $62.4M | $120.0M | ||
| Q2 24 | $59.6M | $271.6M |
| Q1 26 | $470.2M | — | ||
| Q4 25 | $542.6M | $301.7M | ||
| Q3 25 | $498.9M | $274.8M | ||
| Q2 25 | $455.6M | $232.2M | ||
| Q1 25 | $462.1M | $234.4M | ||
| Q4 24 | $519.3M | $228.8M | ||
| Q3 24 | $412.8M | $234.3M | ||
| Q2 24 | $371.4M | $216.6M |
| Q1 26 | $580.6M | — | ||
| Q4 25 | $689.0M | $1.7B | ||
| Q3 25 | $640.5M | $1.6B | ||
| Q2 25 | $567.4M | $1.6B | ||
| Q1 25 | $564.7M | $1.6B | ||
| Q4 24 | $626.7M | $1.7B | ||
| Q3 24 | $523.3M | $1.6B | ||
| Q2 24 | $479.3M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.3M | $123.0M |
| Free Cash FlowOCF − Capex | — | $122.4M |
| FCF MarginFCF / Revenue | — | 59.6% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | 0.81× | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | — | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.3M | — | ||
| Q4 25 | $65.0M | $123.0M | ||
| Q3 25 | $86.0M | $78.4M | ||
| Q2 25 | $52.6M | $72.4M | ||
| Q1 25 | $38.5M | $55.4M | ||
| Q4 24 | $36.6M | $84.6M | ||
| Q3 24 | $57.8M | $-9.0M | ||
| Q2 24 | $50.9M | $67.4M |
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $122.4M | ||
| Q3 25 | $84.7M | $78.3M | ||
| Q2 25 | $52.4M | $72.4M | ||
| Q1 25 | $38.2M | $54.6M | ||
| Q4 24 | $36.4M | $84.1M | ||
| Q3 24 | $57.4M | $-9.2M | ||
| Q2 24 | $50.8M | $67.1M |
| Q1 26 | — | — | ||
| Q4 25 | 25.7% | 59.6% | ||
| Q3 25 | 34.0% | 37.4% | ||
| Q2 25 | 22.2% | 38.5% | ||
| Q1 25 | 17.6% | 30.7% | ||
| Q4 24 | 17.9% | 46.2% | ||
| Q3 24 | 27.9% | -5.8% | ||
| Q2 24 | 25.8% | 46.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 0.3% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.4% | ||
| Q4 24 | 0.1% | 0.3% | ||
| Q3 24 | 0.2% | 0.2% | ||
| Q2 24 | 0.0% | 0.2% |
| Q1 26 | 0.81× | — | ||
| Q4 25 | 1.63× | 7.25× | ||
| Q3 25 | 2.56× | 2.49× | ||
| Q2 25 | 1.46× | 6.05× | ||
| Q1 25 | 1.23× | 22.92× | ||
| Q4 24 | 0.36× | 6.75× | ||
| Q3 24 | 1.75× | -0.96× | ||
| Q2 24 | 1.71× | 3.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APPF
| Value Added Services | $164.7M | 63% |
| Subscription Services | $58.2M | 22% |
| Other | $39.3M | 15% |
COLL
Segment breakdown not available.
